ESR1 and neoplasm: However, the role of immunity has emerged during the last decade with the demonstration of a favorable prognostic impact of the presence of tumor-infiltrating lymphocytes (TILs) [1-3] and of gene expression signatures of immune response, notably for ER-negative, highly proliferative tumors [4-8].